Fabry's disease medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Fabry's disease}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ==Medical Therapy=..." |
Ghsanadgol (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
=== | === Specific Treatment === | ||
* Enzyme: alpha-galactosidase A enzyme | |||
** Enzyme replacement therapy: recombinant human enzyme | |||
*** Agalsidase alfa( Replagal) | |||
*** Agalsidase beta (Fabrazyme) | |||
** Increase the enzyme activity if GLA gene positive: Migalastat | |||
** | |||
==References== | ==References== | ||
Revision as of 14:29, 15 April 2022
|
Fabry's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fabry's disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Fabry's disease medical therapy |
|
Risk calculators and risk factors for Fabry's disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Medical Therapy
Specific Treatment
- Enzyme: alpha-galactosidase A enzyme
- Enzyme replacement therapy: recombinant human enzyme
- Agalsidase alfa( Replagal)
- Agalsidase beta (Fabrazyme)
- Increase the enzyme activity if GLA gene positive: Migalastat
- Enzyme replacement therapy: recombinant human enzyme